aminoimidazole carboxamide has been researched along with Experimental Hepatoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, XL; Li, B; Li, L; Li, MY; Li, ZQ; Lu, W; Zhou, TY | 1 |
Javaux, F; van den Berghe, G; Vincent, MF; Wagner, DR | 1 |
2 other study(ies) available for aminoimidazole carboxamide and Experimental Hepatoma
Article | Year |
---|---|
Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma.
Topics: Aminoimidazole Carboxamide; Animals; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Female; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; MCF-7 Cells; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays | 2013 |
Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside. Lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells.
Topics: Adenosine Kinase; Aminoimidazole Carboxamide; Animals; Dihydroxyacetone; Erythrocytes; Fructosephosphates; Glucose-6-Phosphate; Glucosephosphates; Glycolysis; Humans; Lactates; Lactic Acid; Liver Neoplasms, Experimental; Male; Myocardium; Rabbits; Rats; Ribonucleosides; Ribonucleotides; Tumor Cells, Cultured | 1995 |